Alector, Inc. (ALEC) Discusses Strategic Advances in Next Generation Neurodegeneration Therapies and Pipeline Developments TranscriptSeeking Alpha • 10/13/26
Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled PipelineGlobeNewsWire • 10/07/26
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson's Disease and Other Neurodegenerative DiseasesGlobeNewsWire • 10/05/26
Alector, Inc. (ALEC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
Alector, Inc. (ALEC) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Prepared Remarks TranscriptSeeking Alpha • 09/15/26
Alector Reports Second Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • 08/06/26
Alector Reports First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • 05/07/26
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 05/07/26
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer's Disease Following Interim Futility AnalysisGlobeNewsWire • 04/29/26
Alector (ALEC)'s Technical Outlook is Bright After Key Golden CrossZacks Investment Research • 03/10/26
Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles24/7 Wall Street • 03/10/26
Alector, Inc. (ALEC) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha • 03/06/26
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 02/25/26
INVESTOR ALERT: Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary EndpointPRNewsWire • 01/29/26
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business OfficerGlobeNewsWire • 12/12/25
Alector, Inc. (ALEC) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 TranscriptSeeking Alpha • 12/08/25